Nivolumab vs Simvastatin
Nivolumab vs Simvastatin: Overview
This comparison examines the pharmacological differences between Nivolumab and Simvastatin.
Mechanism of Action
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Simvastatin: Prodrug converted to active form that inhibits HMG-CoA reductase.
Pharmacokinetics
Half-life: Nivolumab — 27 days; Simvastatin — 2 hours.
Chemical Properties
Molecular Formula: Simvastatin — C25H38O5.
Molecular Weight: Simvastatin — 418.5700 g/mol.
Type: Nivolumab — Antibody; Simvastatin — Small molecule.